Search form

The Quidel Triage BNP Test is a rapid, point-of-care fluorescence immunoassay used with the Quidel Triage MeterPro. The test is used to measure B-type natriuretic peptide (BNP) in EDTA anticoagulated whole blood or plasma specimens. The Quidel Triage BNP Test is the first rapid BNP immunoassay indicated for risk stratification for both acute coronary syndrome and heart failure.

References

Quidel Triage BNP [Package Insert]. San Diego, CA: Alere, Inc.; 2015.

Maisel AS, et al., “Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure”. N Engl J Med 2002; 347: 161−8.

Cowie MR, et al., “Recommendations on the clinical use of B-type Natriuretic Peptide testing (BNP or NTproBNP) in the UK and Ireland”, The British Journal of Cardiology 2010; 17:76-80.

Select a Language

Features & Benefits

Benefit

Aid in the diagnosis of CHF

Aid in the assessment of severity of CHF

Risk stratify patients with ACS

Risk stratify patients with HF

Allows immediate consultation with patients on test results

Improves clinical, economic and operational outcomes

Product Specifications

Product Spec NameProduct Spec Data
Sample type

Plasma or whole blood in EDTA

Time to results

Yields results in about 15 minutes

Ordering Information

Catalog NumberDescription
98000XR

Quidel Triage BNP Test

98000XREU (Worldwide)

Quidel Triage BNP Test

98013XR (Worldwide)

Quidel Triage BNP Control 1

98014XR (Worldwide)

Quidel Triage BNP Control 2

98015XR (Worldwide)

Quidel Triage BNP Calibration Verification

88753 (Worldwide)

Quidel Triage Total 5 Control 1

88754 (Worldwide)

Quidel Triage Total 5 Control 2

88755 (Worldwide)

Quidel Triage Total 5 Calibration Verification